“Curious” and “largely cosmetic” were two of the opinions among analysts on Thursday as they sought to explain Barclays’ decision to sell more than $12.3bn of risky credit assets to a new company. Barclays loaned the new company, Protium, the money to buy the assets, thus replacing the volatility surrounding risky assets with regular cash flows from interest payments. The question, say analysts, is whether the merits of protecting against further problems with the assets outweigh the amount of upside being handed to the new fund.
